LBG
DGX icon

Lloyds Banking Group’s Quest Diagnostics DGX Stock Holding History

Lloyds Banking Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,816
Closed -$170K – 148
2014
Q3 		$170K Sell
2,816
-967
-26% -$59.6K 0.05% 292
2014
Q2 		$222K Sell
3,783
-50,495
-93% -$2.96M 0.05% 258
2014
Q1 		$3.14M Buy
54,278
+1,791
+3% +$96K 0.03% 379
2013
Q4 		$2.81M Buy
52,487
+3,408
+7% +$202K 0.03% 402
2013
Q3 		$3.03M Sell
49,079
-5,699
-10% -$341K 0.03% 356
2013
Q2 		$3.32M Buy
+54,778
New +$3.26M 0.03% 322

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Lloyds Banking Group's DGX Position: Q4 2014 in Review

Lloyds Banking Group sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 2,816 shares — an estimated $170K sold.

Lloyds Banking Group first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $3.32M in Q2 2013. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Lloyds Banking Group reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 2,816 Quest Diagnostics shares in Q4 2014, an estimated $170K.
  • Lloyds Banking Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Quest Diagnostics position peaked at $3.32M in Q2 2013.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.